Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	77	73	67	164	132	119
Market Cap Growth	40.66%	8.31%	-58.91%	23.85%	11.02%	248.26%
Enterprise Value	95	86	46	140	120	108
Last Close Price	1.03	1.17	1.12	2.75	2.74	2.90
PE Ratio	-	-2.21	-2.04	427.82	-7.00	-3.58
PS Ratio	9.21	8.88	50.80	5.55	16.78	54.92
PB Ratio	-3.43	-4.59	6.36	4.32	15.12	10.70
P/FCF Ratio	-4.82	-3.67	-4.95	-15.29	-10.06	-4.40
P/OCF Ratio	-5.08	-4.03	-5.04	-15.29	-10.10	-4.41
EV/Sales Ratio	12.66	10.46	34.95	4.72	15.16	49.88
EV/EBITDA Ratio	-4.17	-3.47	-1.54	-310.97	-6.74	-3.60
EV/EBIT Ratio	-4.16	-3.46	-1.53	-222.69	-6.67	-3.58
EV/FCF Ratio	-5.31	-4.32	-3.41	-13.01	-9.09	-4.00
Debt / Equity Ratio	-1.68	-2.70	3.32	0.02	0.23	0.57
Debt / FCF Ratio	-2.36	-2.16	-2.59	-0.06	-0.15	-0.24
Asset Turnover	0.21	0.19	0.03	0.95	0.34	0.06
Quick Ratio	5.00	4.27	8.34	8.71	1.74	2.07
Current Ratio	5.07	4.42	8.54	9.08	1.82	2.31
Return on Equity (ROE)	-	-	-135.63%	1.61%	-182.83%	-176.96%
Return on Assets (ROA)	-44.05%	-36.40%	-40.17%	-1.26%	-48.63%	-53.43%
Return on Capital (ROIC)	-60.12%	-42.57%	-44.78%	-1.59%	-79.19%	-74.04%
Earnings Yield	-43.46%	-44.49%	-48.87%	0.23%	-13.74%	-25.78%
FCF Yield	-26.18%	-27.27%	-20.19%	-6.54%	-9.94%	-22.70%
Buyback Yield / Dilution	-10.50%	-2.66%	-0.50%	-28.81%	-21.84%	-24.20%
Total Shareholder Return	-10.50%	-2.66%	-0.50%	-28.81%	-21.84%	-24.20%

Source: S&P Capital IQ. Standard template. Financial Sources.